Cargando…
Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches
Hereditary diffuse gastric cancer is an autosomal dominant syndrome characterized by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is caused by inactivating mutations in the tumor suppressor gene CDH1. Genetic testing technologies have become more efficient over the years...
Autores principales: | Cosma, Lidia-Sabina, Schlosser, Sophie, Tews, Hauke C., Müller, Martina, Kandulski, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319245/ https://www.ncbi.nlm.nih.gov/pubmed/35887173 http://dx.doi.org/10.3390/ijms23147821 |
Ejemplares similares
-
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
por: Tümen, Deniz, et al.
Publicado: (2022) -
HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022) -
Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose
por: Allgaier, Raphael, et al.
Publicado: (2023) -
Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell
por: El Rami, Fadi E., et al.
Publicado: (2020) -
Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)